Eckert & Ziegler SE

Eckert & Ziegler SE is a German specialty company that focuses on the development, production, and distribution of isotope‑based products and solutions. Its portfolio includes radionuclides for medical imaging and radiotherapy, sealed sources for industrial irradiation, environmental monitoring devices, and research isotopes used in laboratories. The company serves a diverse customer base that comprises hospitals, nuclear medicine centres, industrial manufacturers, governmental agencies, and academic institutions. By integrating isotope chemistry, target technology, and radiation safety expertise, Eckert & Ziegler provides end‑to‑end solutions ranging from raw material supply to finished product delivery. Its activities span the entire lifecycle of radioactive materials, from production to application and disposal.

Eckert & Ziegler maintains a global operational footprint with production sites and subsidiaries located in several countries across Europe, North America, and Asia. This international network allows the company to supply customers worldwide while complying with local regulatory requirements. The firm’s scale is evident in its capacity to manage both large‑scale isotope projects and customized, small‑batch orders for specialized research applications. Its logistics infrastructure meets the stringent transport and safety standards that govern the shipment of radioactive materials. As a result, Eckert & Ziegler is regarded as a dependable partner for routine and high‑complexity isotope needs in diverse markets.

A distinguishing attribute of Eckert & Ziegler is its deep specialization in radionuclide production and isotope separation technologies, which are supported by a portfolio of patents and proprietary target designs. The company operates under strict regulatory oversight, holding licenses from authorities such as the German Federal Office for Radiation Protection, the U.S. Nuclear Regulatory Commission, and international bodies like EURATOM. This regulatory competence allows it to navigate complex licensing processes for both civilian and medical uses of radioactive material. Eckert & Ziegler also emphasizes radiation safety and quality management, maintaining certifications such as ISO 9001 and ISO 13485 for its medical product lines. These capabilities reinforce its reputation as a trusted supplier in highly regulated markets. Structurally, Eckert & Ziegler SE is a publicly traded European company (Societas Europaea) listed on the Frankfurt Stock Exchange under the ticker symbol EZU, with its headquarters situated in Berlin, Germany. The corporate structure comprises several wholly‑owned subsidiaries that operate under the Eckert & Ziegler brand, each focusing on specific market segments such as isotope products, radiation therapy, radiopharma, and environmental monitoring. In early February 2025 the company disclosed a cyber attack that targeted portions of its IT infrastructure, prompting proactive system shutdowns and the engagement of an internal task force alongside external forensic specialists. While the incident led to temporary internet disconnections, Eckert & Ziegler reported that production remained largely unaffected and leadership anticipates no material adverse impact on business continuity.